» Articles » PMID: 10348780

Rifampin and Rifabutin Resistance Mechanism in Helicobacter Pylori

Overview
Specialty Pharmacology
Date 1999 May 29
PMID 10348780
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Eighty-one clinical isolates of Helicobacter pylori showed no resistance to rifampin (MIC range, 0.032 to 2 microg/ml; MIC at which 50% of isolates are inhibited [MIC50], 0.25 microg/ml). The MIC50 of rifabutin was 0.008 microg/ml (n = 16). All resistant laboratory mutants of H. pylori ATCC 43504 showed amino acid exchanges in codons 524 to 545 or codon 585 of the rpoB gene, corresponding to the gene sequences from Mycobacterium tuberculosis and Escherichia coli.

Citing Articles

Prevalence and antimicrobial resistance of highly virulent cagA-positive Helicobacter pylori strains in Southern Poland.

Klesiewicz K, Orczykowska-Kotyna M, Skiba-Kurek I, Empel J, Kania K, Karczewska E Eur J Clin Microbiol Infect Dis. 2024; 44(2):405-416.

PMID: 39688753 DOI: 10.1007/s10096-024-05018-z.


Change in Diagnosis of Infection in the Treatment-Failure Era.

Spagnuolo R, Scarlata G, Paravati M, Abenavoli L, Luzza F Antibiotics (Basel). 2024; 13(4).

PMID: 38667033 PMC: 11047737. DOI: 10.3390/antibiotics13040357.


Antibiotic Resistance of : Mechanisms and Clinical Implications.

Hasanuzzaman M, Bang C, Gong E J Korean Med Sci. 2024; 39(4):e44.

PMID: 38288543 PMC: 10825452. DOI: 10.3346/jkms.2024.39.e44.


Exploring Alternative Treatment Choices for Multidrug-Resistant Clinical Strains of in Mongolia.

Khangai A, Saruuljavkhlan B, Azzaya D, Gantuya B, Oyuntsetseg K, Akada J Microorganisms. 2023; 11(12).

PMID: 38137996 PMC: 10745380. DOI: 10.3390/microorganisms11122852.


Whole Genome Sequencing for Studying Antimicrobial Resistance.

Fernandez-Caso B, Miqueleiz A, Alarcon T Antibiotics (Basel). 2023; 12(7).

PMID: 37508231 PMC: 10376898. DOI: 10.3390/antibiotics12071135.


References
1.
Nolte O . Rifampicin resistance in Neisseria meningitidis: evidence from a study of sibling strains, description of new mutations and notes on population genetics. J Antimicrob Chemother. 1997; 39(6):747-55. DOI: 10.1093/jac/39.6.747. View

2.
Tomb J, White O, Kerlavage A, Clayton R, Sutton G, Fleischmann R . The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997; 388(6642):539-47. DOI: 10.1038/41483. View

3.
Enright M, Zawadski P, Pickerill P, Dowson C . Molecular evolution of rifampicin resistance in Streptococcus pneumoniae. Microb Drug Resist. 1998; 4(1):65-70. DOI: 10.1089/mdr.1998.4.65. View

4.
Perri F, Festa V, Andriulli A . Treatment of antibiotic-resistant Helicobacter pylori. N Engl J Med. 1998; 339(1):53. DOI: 10.1056/NEJM199807023390116. View

5.
Severinov K, Soushko M, Goldfarb A, Nikiforov V . Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J Biol Chem. 1993; 268(20):14820-5. View